We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · May 01, 2014

Risk for Recurrence of GIST After Adjuvant Imatinib



Additional Info

Risk Factors for Gastrointestinal Stromal Tumor Recurrence in Patients Treated With Adjuvant Imatinib
Cancer 2014 Apr 15;[EPub Ahead of Print], H Joensuu, M Eriksson, KS Hall, JT Hartmann, D Pink, J Schütte, G Ramadori, P Hohenberger, J Duyster, SE Al-Batran, M Schlemmer, S Bauer, E Wardelmann, M Sarlomo-Rikala, B Nilsson, H Sihto, KV Ballman, M Leinonen, RP Dematteo, P Reichardt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading